Trial reportBMC health services research2012
Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings.
Trial report in BMC health services research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review.Drug safety · 2016Pooled it
- Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review.International journal of clinical pharmacy · 2014Pooled it
- The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients with Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023Trial
- Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China.Global health, science and practice · 2021Trial
- Primary health care interventions targeting diabetes, hypertension or dyslipidemia in Malaysia: A scoping review.PloS one · 2026Article
- Understanding the role and organization of health workers delivering non-communicable disease management in primary care in low- and middle-income countries: a scoping review.BMC primary care · 2025Article
- Article
- Article
- Yemeni Physicians' Attitudes and Perceived Barriers Toward Ward-Based Clinical Pharmacist in Hospital Settings.Integrated pharmacy research & practice · 2024Article
- Drug-related problems among hospitalized hypertensive and heart failure patients and physician acceptance of pharmacists' interventions at a teaching hospital in Ghana.Health science reports · 2022Article
- Understandings, Attitudes, and Barriers About Diabetes Care: Analysis of Factors Influencing Community Pharmacists in China.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Article
- The Evolving Role and Impact of Integrating Pharmacists into Primary Care Teams: Experience from Ontario, Canada.Pharmacy (Basel, Switzerland) · 2020Review
- Prevalence of potentially inappropriate medications among geriatric residents in nursing care homes in Malaysia: a cross-sectional study.International journal of clinical pharmacy · 2019Article
- Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: a pilot study.BMC health services research · 2019Article
- Opinions of Community Pharmacists About Collaboration with General Practitioners: A Descriptive Pilot Study After New Legislation in Turkey.Turkish journal of pharmaceutical sciences · 2018Article
- Investigating the Relative Significance of Drug-Related Problem Categories.Pharmacy (Basel, Switzerland) · 2017Review
- Exploring the extended role of the community pharmacist in improving blood pressure control among hypertensive patients in a developing setting.Journal of pharmaceutical policy and practice · 2017Article
- Chronic care model in primary care: can it improve health-related quality of life?Integrated pharmacy research & practice · 2016Article
- Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach.BMC health services research · 2015Article
- Patient and physician adherence in hypertension management.Journal of clinical hypertension (Greenwich, Conn.) · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe roles of pharmacists have evolved from product oriented, dispensing of medications to more patient-focused services such as the provision of pharmaceutical care. Such pharmacy service is also becoming more widely practised in Malaysia but is not well documented. Therefore, this study is warranted to fill this information gap by identifying the types of pharmaceutical care issues (PCIs) encountered by primary care patients with diabetes mellitus, hypertension or hyperlipidaemia in Malaysia.
methodsThis study was part of a large controlled trial that evaluated the outcomes of multiprofessional collaboration which involved medical general practitioners, pharmacists, dietitians and nurses in managing diabetes mellitus, hypertension and hyperlipidaemia in primary care settings. A total of 477 patients were recruited by 44 general practitioners in the Klang Valley. These patients were counselled by the various healthcare professionals and followed-up for 6 months.
resultsOf the 477 participants, 53.7% had at least one PCI, with a total of 706 PCIs. These included drug-use problems (33.3%), insufficient awareness and knowledge about disease condition and medication (20.4%), adverse drug reactions (15.6%), therapeutic failure (13.9%), drug-choice problems (9.5%) and dosing problems (3.4%). Non-adherence to medications topped the list of drug-use problems, followed by incorrect administration of medications. More than half of the PCIs (52%) were classified as probably clinically insignificant, 38.9% with minimal clinical significance, 8.9% as definitely clinically significant and could cause patient harm while one issue (0.2%) was classified as life threatening. The main causes of PCIs were deterioration of disease state which led to failure of therapy, and also presentation of new symptoms or indications. Of the 338 PCIs where changes were recommended by the pharmacist, 87.3% were carried out as recommended.
conclusionsThis study demonstrates the importance of pharmacists working in collaboration with other healthcare providers especially the medical doctors in identifying and resolving pharmaceutical care issues to provide optimal care for patients with chronic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.